Finanzwire Finanzwire
Basculer en Français
11332 Companies
251872 Keywords
181146 Articles
137666 Press releases
Headlines Articles Press releases Ferrosa Therapeutics AG Remove
  1. Home
  2. Companies
  3. Ferrosa Therapeutics AG
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/23/2026 at 14:10, 6 months 19 days ago

    Ferrosa Therapeutics Secures Seed Financing for Innovative Anemia Treatment

    Chronic Diseases Seed Financing Bispecific Antibody Ferrosa Therapeutics Anemia Treatment
  • PRESS RELEASE

    published on 04/23/2026 at 14:05, 6 months 19 days ago

    FERROSA THERAPEUTICS ANNOUNCES SEED FINANCING TO ADVANCE A FIRST-IN-CLASS BISPECIFIC ANTIBODY PROGRAM FOR ANEMIA OF INFLAMMATION

    Ferrosa Therapeutics announces USD 3.5 Million seed financing to advance first-in-class bispecific antibody program for anemia of inflammation. Company targets chronic kidney disease, autoimmune disease, and cancer
    Seed Financing Bispecific Antibody Ferrosa Therapeutics Anemia Of Inflammation Forty51 Ventures
    Logo of Ferrosa Therapeutics AG
Accesswire
  • Published on 11/13/2026 at 02:40, 6 hours 2 minutes ago

    Jaguar Mining Reports Third Quarter 2026 Results with 67% Growth in Adjusted Net Income and 46% Higher Adjusted EBITDA

  • Published on 11/13/2026 at 02:10, 6 hours 32 minutes ago

    Amarc to Participate in Consolidation of Aurora West Through Aurora Minerals LTD

  • Published on 11/12/2026 at 23:25, 9 hours 17 minutes ago

    Renegade Gold Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million

  • Published on 11/12/2026 at 23:05, 9 hours 37 minutes ago

    Caldwell Reports Fourth Quarter and Full Year Fiscal 2026 Results; Increases Quarterly Dividend and Declares a Special Dividend

  • Published on 11/12/2026 at 23:00, 9 hours 42 minutes ago

    Redwood AI Announces Chemical Risk Analysis Update to its AI-Powered Reactosphere Platform to Support Faster Reaction Safety Screening

View all ACCESSWIRE
EQS Group
  • Published on 11/13/2026 at 08:30, 11 minutes ago

    Dahua Pro Challenge 2026 Celebrates Global Installer Expertise and Long-term Collaboration

  • Published on 11/13/2026 at 08:30, 12 minutes ago

    Softing AG: Interim Statement on the 3rd Quarter and First 9 Months of 2026

  • Published on 11/13/2026 at 08:00, 42 minutes ago

    Uzin Utz SE has published its third-quarter financial results: an increase in sales and stable earnings performance despite subdued momentum in the construction sector due to ongoing market headwinds

  • Published on 11/13/2026 at 08:00, 42 minutes ago

    Cairn Homes Plc: Transaction in Own Shares

  • Published on 11/13/2026 at 07:48, 53 minutes ago

    Nagarro releases unaudited Q3 2026 results, posts 2.7% constant currency growth for 9 months ended September 2026

View all EQS
Les Echos
  • Published on 11/12/2026 at 23:12, 9 hours 29 minutes ago

    Belgrano continues the implementation of its public share buyback offer (OPRA)

  • Published on 11/12/2026 at 18:36, 14 hours 5 minutes ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026

  • Published on 11/12/2026 at 18:00, 14 hours 42 minutes ago

    Information concerning the total number of voting rights and shares in the share capital as of November 12, 2026

  • Published on 11/12/2026 at 17:40, 15 hours 2 minutes ago

    Financial information for the period ended 30 September 2026

  • Published on 11/12/2026 at 08:56, 23 hours 45 minutes ago

    Number of shares and voting rights - October 2026 (In French only)

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy